Jounce Therapeutics
Patents, Design & Utilities
Last updated:
List of all Jounce Therapeutics patents 20 in total
Status | Patent |
---|---|
Application | Utility: Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing) Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: Antibodies to LILRB2 Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: Anti-ICOS Antibodies for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: Methods of Treating Cancer Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Methods of Treating Cancer Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Gene Signatures for Determining ICOS Expression Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: ANTIBODIES AND FUSION PROTEINS THAT BIND TO CCR8 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: Antibodies to ICOS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Gene signatures for determining ICOS expression Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: Anti-PD-1 Antibodies and Uses Thereof Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: ANTIBODIES TO LILRB2 Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Antibodies to LILRB2 Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: ANTIBODIES TO LILRB2 Filling date: 6 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: Antibodies to PD-1 and uses thereof Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Methods of treating conditions with antibodies that bind B7-H4 Filling date: 6 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Antibodies to ICOS Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: Compositions and Methods for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Showing 1 to 20 of 20 patents.